The determination of cut-off values for adhesion molecules, particularly VCAM-1, has already been proven beneficial for the detection of pathologies associated with atherosclerosis, such as peripheral arterial disease, atrial fibrillation, post-acute myocardial infarction, and heart failure [44,45,46]. This evidence concerns the gene VCAM1 and atrial fibrillation.